Thymosin Alpha-1

What is Thymosin Alpha-1?

Thymosin Alpha-1 (Tα1) is a naturally occurring peptide derived from thymosin fraction 5, a thymic extract first isolated in the 1970s. It is produced by the thymus gland — the primary organ responsible for T-cell maturation and immune education. Like many biological compounds, Tα1 levels decline with age as the thymus involutes, contributing to the immunosenescence (immune aging) that increases susceptibility to infection, cancer, and chronic disease.

Tα1 has been approved in over 35 countries for the treatment of hepatitis B, hepatitis C, and as an adjunct to cancer therapy. It has been studied extensively for its ability to enhance T-cell function, stimulate natural killer (NK) cell activity, modulate dendritic cell function, and reduce the chronic low-grade inflammation (inflammaging) that drives many age-related diseases.

At HydraSpa, Thymosin Alpha-1 is prescribed as part of our immune optimization, longevity, and cancer wellness programs. It is particularly valuable for individuals with compromised immune function, chronic infections, autoimmune conditions, or those seeking proactive immune resilience as part of a comprehensive longevity protocol.

Restoring immune intelligence

T-Cell Maturation & Activation

Tα1 promotes the differentiation and maturation of T-cell precursors in the thymus and periphery — increasing the number and functional capacity of CD4+ helper T-cells and CD8+ cytotoxic T-cells.

NK Cell Enhancement

Tα1 stimulates natural killer cell activity — enhancing the immune system's first-line defense against virally infected cells and cancer cells.

Dendritic Cell Modulation

Tα1 activates dendritic cells — the immune system's primary antigen-presenting cells — improving the quality and specificity of adaptive immune responses.

Anti-Inflammatory Regulation

Tα1 modulates the balance between pro-inflammatory and anti-inflammatory cytokines — reducing chronic low-grade inflammation (inflammaging) while preserving the immune system's ability to mount acute responses.

Antioxidant Gene Expression

Tα1 upregulates antioxidant pathways including superoxide dismutase and glutathione — reducing oxidative stress that contributes to immune dysfunction and cellular aging.

What patients report

—

Enhanced T-cell function and immune surveillance

—

Improved resistance to viral and bacterial infections

—

Reduced chronic inflammation and inflammaging

—

Support for cancer immunosurveillance

—

Improved response to vaccines

—

Support for autoimmune condition management

—

Reduced fatigue associated with immune dysfunction

—

Antioxidant protection and cellular longevity support

—

Adjunct support during and after cancer treatment

Who may benefit from Thymosin Alpha-1?

—

Individuals with frequent infections or compromised immune function

—

Those with chronic viral infections (EBV, CMV, chronic Lyme, long COVID)

—

Cancer patients and survivors seeking immune support alongside conventional treatment

—

Individuals with autoimmune conditions seeking immune modulation

—

Health-conscious adults seeking proactive immune resilience and longevity support

—

Those with elevated inflammatory markers (CRP, IL-6) seeking anti-inflammatory support

—

Patients in our cancer wellness or longevity programs

Frequently asked questions

Is Thymosin Alpha-1 approved by the FDA?

Thymosin Alpha-1 is approved in over 35 countries for hepatitis B, hepatitis C, and as a cancer therapy adjunct. In the United States, it is available as a compounded medication from licensed 503A pharmacies and prescribed by clinicians for individual patient use. It is not FDA-approved as a drug in the US, but it has an extensive international clinical record.

Can Thymosin Alpha-1 help with long COVID or post-viral fatigue?

Emerging research and clinical experience suggest that Tα1 may be beneficial for long COVID and post-viral syndromes — conditions characterized by immune dysregulation, chronic inflammation, and T-cell exhaustion. While large-scale clinical trials are ongoing, many clinicians are using Tα1 as part of comprehensive long COVID protocols. Your clinician will assess whether it is appropriate for your specific situation.

Is Thymosin Alpha-1 safe for people with autoimmune conditions?

Tα1 is an immune modulator, not an immune stimulator — it helps regulate and balance immune function rather than simply amplifying it. This makes it potentially beneficial for autoimmune conditions where immune dysregulation (rather than simple deficiency) is the underlying issue. However, autoimmune conditions require careful clinical assessment before prescribing. Your clinician will review your specific diagnosis and current treatments.

Can I combine Thymosin Alpha-1 with IV therapy?

Yes — and this is a highly effective combination. High-dose Vitamin C IV, Glutathione IV, and Myers' Cocktail all support immune function through complementary mechanisms. Combining Tα1 with IV nutritional therapy creates a comprehensive immune support protocol that addresses both cellular immune function (Tα1) and the nutritional substrate required for optimal immune activity (IV therapy).

How long before I notice immune improvements?

Many patients report improved energy and reduced infection frequency within 4–6 weeks of starting Tα1. Measurable improvements in immune markers (lymphocyte counts, NK cell activity) are typically seen at 8–12 weeks. For chronic conditions, longer treatment courses are generally required for sustained benefit.

Our services